These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Evaluation of usefulness in surfactant protein D as a predictor of mortality in myositis-associated interstitial lung disease. Kaieda S, Gono T, Masui K, Nishina N, Sato S, Kuwana M, A Multicenter Retrospective Cohort of Japanese Patients with Myositis-associated ILD (JAMI) investigators. PLoS One; 2020; 15(6):e0234523. PubMed ID: 32525903 [Abstract] [Full Text] [Related]
12. Clinical characteristics of dermatomyosits/polymyositis associated interstitial lung disease according to the autoantibody. Kishaba T, McGill R, Nei Y, Ibuki S, Momose M, Nishiyama K, Nagano H, Yamashiro S. J Med Invest; 2018; 65(3.4):251-257. PubMed ID: 30282869 [Abstract] [Full Text] [Related]